12 completed. 12 Phase 2, 5 Phase 3, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Completed 12 |
| Phase 3 | 5 | Completed 5 |
| Phase 1 | 3 | Completed 3 |
Follow Diabetes Type 2: new trials by email Literature Review of Diabetes Type 2 trials Research Report on Diabetes Type 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus ORMD-0801, Placebo Comparator - Diabetes Type 2 | Phase 2 | Completed | Oramed, Ltd. | 188 | 2015-07-27 | 2019-11-13 |
| A Study to Evaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes Patients DM199, Placebo - Diabetes Type 2 | Phase 1 / Phase 2 | Completed | DiaMedica Therapeutics Inc | 98 | 2013-04-01 | 2014-12-19 |
| Grain Exercise Trial - Whole Grain Versus no Grain With or Without Physiotherapy-promoted Exercise for Waist Loss Diet A, Diet B, Physiotherapy - Abdominal Obesity, Cardiovascular Diseases | Phase 2 / Phase 3 | Completed | Lund University | 105 | 2010-08-01 | 2017-06-20 |
| Safety Study of BMS-770767 in Subjects With Type 2 Diabetes BMS-770767, Placebo, Metformin - Diabetes Type 2 | Phase 2 | Completed | Bristol-Myers Squibb | 76 | 2010-05-01 | 2015-10-12 |
| A Study of OPC-262 in Patients With Type 2 Diabetes OPC-262 2.5 mg, OPC-262 5 mg, Placebo - Diabetes Type 2 | Phase 2 / Phase 3 | Completed | Kyowa Kirin Co., Ltd. | 255 | 2009-09-01 | 2014-01-08 |
| Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes Patients DMMET-01, Metformin Hydrochloride - Diabetes Type 2 | Phase 2 / Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 20 | 2009-03-01 | 2010-05-18 |
| Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP) DMMET-01, Placebo - Diabetes Type 2 | Phase 2 | Completed | Laboratorios Silanes S.A. de C.V. | 20 | 2008-07-01 | 2009-07-16 |
| Gait and Balance of Diabetes Type 2 Patients Physiotherapy - Diabetes Type 2 | Phase 2 / Phase 3 | Completed | University Hospital, Geneva | 71 | 2007-09-01 | 2010-01-14 |
| Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy N-acetylcysteine - Diabetic Nephropathy, Chronic Kidney Disease | Phase 2 / Phase 3 | Completed | Shiraz University of Medical Sciences | 60 | 2007-01-01 | 2007-11-12 |
| Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy Aliskiren - Diabetes Type 2 | Phase 1 / Phase 2 | Completed | Novartis | 24 | 2005-09-01 | 2007-11-29 |
| Time Course of the Antiproteinuric and Blood Pressure Lowering Effects After Initiation of Renin Inhibition With Aliskiren in Type 2 Diabetes Aliskiren - Diabetes Type 2 | Phase 1 / Phase 2 | Completed | Novartis | 18 | 2005-08-01 | 2016-09-23 |
| Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes Technosphere Insulin Inhalation Powder - Diabetes Type 2 | Phase 2 | Completed | Mannkind Corporation | 24 | 2004-08-01 | 2009-07-08 |
Diabetes Mellitus, Type 2 (12) · Diabetes Mellitus (3) · Cardiovascular Diseases (1) · Diabetic Nephropathies (1) · Glucose Intolerance (1) · Hypertension (1) · Obesity, Abdominal (1) · Overweight (1) · Proteinuria (1) · Renal Insufficiency, Chronic (1) · Stroke (1) · Weight Loss (1)
Endocrine System Diseases (12) · Glucose Metabolism Disorders (12) · Metabolic Diseases (12) · Nutritional and Metabolic Diseases (12) · Diabetes Mellitus (9) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Body Weight (1) · Body Weight Changes (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Chronic Disease (1) · Diabetes Complications (1) · Disease Attributes (1)
Metformin (2) · Physical Therapy Modalities (2) · aliskiren (2) · Acetylcysteine (1) · BMS-770767 (1) · DM199 (1) · Exercise (1) · Insulin (1) · ORMD-0801 (1) · Whole Grains (1)
Laboratorios Silanes S.A. de C.V. (2) · Novartis (2) · Bristol-Myers Squibb (1) · DiaMedica Therapeutics Inc (1) · Kyowa Kirin Co., Ltd. (1) · Lund University (1) · Mannkind Corporation (1) · Oramed, Ltd. (1) · Shiraz University of Medical Sciences (1) · University Hospital, Geneva (1)
United States (3) · Denmark (2) · Mexico (2) · Australia (1) · Canada (1) · Iran (1) · Japan (1) · Netherlands (1) · South Korea (1) · Sweden (1) · Switzerland (1)
Joel M Neutel, M.D. (1) · Kaatsuhisa Saito (1) · Lara E Allet, MPtSc (1) · Manuel Gonzalez, PHD (1) · Salah Hadi, MD, MSc (1) · Staffan Lindeberg, MD PhD (1)
PMID 18579384, PMID 19138520, PMID 19587362, PMID 19900232, PMID 19921145, PMID 22974412, PMID 38639002, PMID 41039470
2009 (1)